ArticleGastroenterology & hepatology2025
Dual-Targeted Therapy With Risankizumab and Upadacitinib Is Clinically and Biochemically Effective in Medically Complex CD.
No numbers read from the abstract.
ArticleGastroenterology & hepatology2025
No numbers read from the abstract.